Generic Name and Formulations:
Ketorolac tromethamine 0.5%; oph soln; contains benzalkonium chloride.
Indications for ACULAR:
Ocular itch due to seasonal allergic conjunctivitis. Post-op inflammation after cataract extraction.
Adults and Children:
<3yrs: not established. ≥3yrs: 1 drop 4 times daily. Post-op: begin 24hrs post-op and continue for 2 weeks.
Do not administer while wearing contacts. Bleeding tendencies. Complicated or repeat ocular surgeries. Corneal defects/denervation. Ocular surface diseases. Diabetes. Rheumatoid arthritis. May delay wound healing. Monitor cornea; discontinue if corneal epithelial breakdown occurs. Hypersensitivity to aspirin. History of asthma. Pregnancy (Cat.C): avoid in late pregnancy. Nursing mothers.
May potentiate oral anticoagulants.
Transient stinging, burning, conjunctival hyperemia, corneal infiltrates, headache, ocular edema, ocular pain/inflammation/irritation, superficial keratitis or infections, allergic reactions, increased ocular bleeding (including hyphemas).
Renal and Urology News Articles
- Kidney Damage in Younger Adults Tied to NSAID Use
- Dialysis and Transplant Patients at Increased Risk for Cancer Death
- Guidelines Updated for Pulmonary Arterial Hypertension in Adults
- Metastatic Prostate Cancer Responds to Novel Radiation Therapy
- Darolutamide Improves Metastasis-Free Survival in CRPC
- Prednisone to Blame for ERA 223 Trial Failure?
- Clinicians Somewhat Favor Shared Decision-Making in Older mCRPC Patients
- Higher Push-Up Capacity Linked to Lower Incidence of CVD Events
- Pembrolizumab Shows Promise for BCG-Unresponsive Bladder Cancer
- Radical Cystectomy Superior to Trimodal Therapy for Muscle-Invasive Bladder Cancer
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)